Market Research Reports

The Global Antibiotics Market has been showing significant growth with a rise in demand for a new generation of antibiotics. Antibiotics Market Size has also been rising and further tend to resolve the antibacterial resistance. Antibiotics Industry Analysis develops approaches in the antibiotic domain providing access to Antibiotics market.  Healthcare Market Research Reports has been grasping these for the further surge in market growth. Report Scope This research report categorizes the antibiotics market by type. The product types are beta–lactams, fluoroquinolones, macrolides, tetracycline and other antibiotic classes. Report Includes - 79 data tables - Comprehensive overview of the global markets for antibiotics - Analyses of the global market trends with data from 2014 to 2018, and projections of compound annual growth rates (CAGRs) through 2023 - Regional dynamics of antibiotics for North America, Europe, Asia-Pacific and Other emerging markets - Country specif...

Summary The Medical Devices sector report, Ophthalmic Diagnostic Equipment Medical Devices Pipeline Assessment, 2019" provides an overview of Ophthalmic Diagnostic Equipment currently in a pipeline stage. The report provides comprehensive information on the pipeline products with a comparative analysis of the products at various stages of development. The report reviews major players involved in pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start, and end dates, and, the number of trials for the key Ophthalmic Diagnostic Equipment pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts. Scope - Extensive coverage of the Ophthalmic Diagnostic Equipment under development - The report reviews details of major pipeline products which includes, product description, licensing and c...

The global market size of Diet Pills is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: Geography segment,  End-use/application segment Competitor segment. For geography segment, regional supply, application-wise, and type-wise demand, major players, the price is presented from 2013 to 2023. This report covers the following regions: North America South America Asia & Pacific Europe MEA (the Middle East and Africa) The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc. For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed. For competitor segment, the report includes global key players of Diet Pills as well as s...

Global Nanomaterials market is expected to reach US$ 98 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025. Presents an in-depth assessment of the global nanomaterials market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. Summary Contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of all the categories. The report also includes assessment of recent development in nanomaterials market. Key trends in terms of partnerships, collaborations and licensing agreement are analyzed with details. Nanomaterials Market, By Materials Type • Advanced & Nanoscale Ceramic Powders • Silver Nanoparticles • Nanoclays • Nanocomposites • Quantum Dots • Nanofibers Nanomaterials Market, By End User • Paintings and Coatings • Elect...

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - 11beta-hydroxysteroid dehydrogenase type 1 is an NADPH-dependent enzyme highly expressed in key metabolic tissues including liver, adipose tissue, and the central nervous system.  In these tissues HSD11B1 reduces cortisone to the active hormone cortisol that activates glucocorticoid receptors. This enzyme plays an important role in obesity and insulin resistance. Covers products from therapy areas: Metabolic Disorders, Central Nervous System, Ophthalmology, Cardiovascular, Immunology and Musculoskeletal Disorders which include indications Type 2 Diabetes, Alzheimers Disease, Dementia Associated With Alzheimers Disease, Obesity, Ocular Hypertension, Open-Angle Glaucoma, Cushings Syndrome, Diabetic Complications, Inflammation, Intracranial Hypertension, Metabolic Syndrome, Muscle Atrophy, Myocard...

Global Neurovascular Devices market is set to touch US$ 5 Billion by 2025. Market growth can be attributed to factors such as growing obese and ageing population, rising patient pool for hemorrhagic and ischemic stroke, ongoing product development & commercialization, increasing demand for minimally invasive procedures for the treatment of neurovascular disease. The Major Companies Dominating Market for its Products, Services and Continuous Product Developments are: Stryker, Medtronic, MicroVention Terumo, Cerenovus (Johnson & Johnson), Penumbra, Microport Scientific Corporation, Integer Holdings Corporation Neurovascular Devices Market, by Products • Coil • Carotid Stent • Clot Removal • Liquid Embolic • Coil Assist Balloon • Coil Assist Stent • Flow Diverter Stent • Micro wire/Catheter Neurovascular Devices Market, by Therapeutic Application • Aneurysm • Intracranial Atherosclerotic Disease (ICAD) • Ischemic Stroke • Arteriovenous Malformation...

Diabetes Insulin Pen Market is anticipated to surpass US$ 4 Billion across the top 5 European countriesof the France, Germany, Italy, Spain and United Kingdom by 2022. “Diabetes Disposable Insulin Pen Market by Country (Germany, United Kingdom, France, Italy, Spain) Analysis, Growth Potential & Demand Forecast 2017 – 2022”  provides comprehensive understanding and unprecedented access to the Diabetes Disposable Insulin Pen Industry entered by the world leading healthcare companies. Summary The research examines the market, demand, competitive landscape and trends of the top 5 European markets of the diabetes disposable insulin pen market. It provides an all-round analysis of overall number of patients with diabetes and insulin users. It offers information on users of insulin pens, specifically focusing on prefilled(disposable) insulin pen users. Annual estimates and forecasts are provided for the period 2017 through 2024. Also, a five-year historic analysis ...

United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025. Presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends.  Offers the most up-to-date industry data on the actual market situation and future outlook for United States influenza vaccines market and includes historic data from 2013 to 2017 and forecasts until 2025. Key market players Novavax Daiichi–Sankyo Mitsubishi TanabePharma and Biondvax Pharmaceuticals Ltd Major companies dominating this market Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca The Latest Industry Data Included • United States Influenza Vaccines Market Size & Analysis (2013 - 2025) • United States Number of Persons Vaccinated • United States Number of Children Vaccinated • United States Number of Adults Vaccinated • United States Influenza Vaccines Pricing Trend...

Global Neuromodulation market is set to surpass US$ 7 Billion by 2025.  The growth of the sector is largely stimulated by an increased uptake of neuromodulation devices, surging prevalence of diseases pertaining to neuromodulation, ageing population, technological advances and deal making activity globally. Contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. provides in-depth analysis and information according to categories such as application, technology, geography, company and competitive landscape. Further key findings • North America is the most attractive market in the neuromodulation market • Chronic pain is the major application segment of the neuromodulation market • With regard to technology, spinal cord stimulation represents the largest segment of the neuromodulation market • The APAC marketplace is slated to grow at the highest rate, a...

Artificial intelligence in medicines market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025.  Artificial intelligence (AI) in medicine is used to analyze complex medical data by approximating human cognition with the help of algorithms and software. The major factors that drive the growth of the AI in medicine market include dearth of skilled healthcare professionals and increase in the processing power of AI systems that is estimated to help improve the efficiency of drug discovery and management of clinical trials. Product Type Segment Review The market is segmented into hardware, software, and service. The software segment occupied the highest share in 2017, owing to continuous software innovation that caters to the requirement in the healthcare sector. Technology Segment Review It is classified into deep learning, querying method, natural language processing, and context aware processing. ...